Case–control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population
暂无分享,去创建一个
Yusuke Nakamura | Naoyuki Kamatani | Michiaki Kubo | Michael J Owen | Atsushi Takahashi | George Kirov | G. Kirov | M. Owen | Yusuke Nakamura | D. Toncheva | V. Milanova | T. Mushiroda | M. Kubo | A. Takahashi | M. O’Donovan | N. Kamatani | I. Dimova | S. Karachanak | Michael C O'Donovan | Taisei Mushiroda | Elitza T Betcheva | Sena K Karachanak | Irina T Zaharieva | Radoslava V Vazharova | Ivanka I Dimova | Vihra K Milanova | Todor Tolev | Draga I Toncheva | R. Vazharova | I. Zaharieva | E. Betcheva | T. Tolev | M. Kubo
[1] John P A Ioannidis,et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.
[2] L. Abramova,et al. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population , 2008, Schizophrenia Research.
[3] Jürgen Gallinat,et al. Molecular Mechanisms of Schizophrenia , 2007, Cellular Physiology and Biochemistry.
[4] J. Hoenicka,et al. C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients , 2006, Acta psychiatrica Scandinavica.
[5] Jarmo Hietala,et al. Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia , 2006, Neuroscience Letters.
[6] Nathaniel G. Hurwitz,et al. Schizoaffective disorders are psychotic mood disorders; there are no schizoaffective disorders , 2006, Psychiatry Research.
[7] D. Collier,et al. Evaluation of a Susceptibility Gene for Schizophrenia: Genotype Based Meta-Analysis of RGS4 Polymorphisms from Thirteen Independent Samples , 2006, Biological Psychiatry.
[8] Brien Riley,et al. Molecular genetic studies of schizophrenia , 2006, European Journal of Human Genetics.
[9] E. Jönsson,et al. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: Evidence from fixed‐ and random‐effects meta‐analyses , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[10] Samir K. Brahmachari,et al. Association of DRD2 gene variant with schizophrenia , 2006, Neuroscience Letters.
[11] Á. Carracedo,et al. Relative efficiency of the linkage disequilibrium mapping approach in detecting candidate genes for schizophrenia in different European populations. , 2005, Genomics.
[12] A. Addington,et al. The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.
[13] S. Faraone,et al. Five NOTCH4 polymorphisms show weak evidence for association with schizophrenia: evidence from meta-analyses , 2005, Schizophrenia Research.
[14] C. P. Morris,et al. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia , 2005, Schizophrenia Research.
[15] J. Lieberman,et al. Amphetamine-Induced Fos is Reduced in Limbic Cortical Regions but not in the Caudate or Accumbens in a Genetic Model of NMDA Receptor Hypofunction , 2004, Neuropsychopharmacology.
[16] K. Någren,et al. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo , 2004, Molecular Psychiatry.
[17] S. Faraone,et al. DRD2 −141C insertion/deletion polymorphism is not associated with schizophrenia: Results of a meta‐analysis , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[18] M. Neville,et al. Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 , 2004, Human mutation.
[19] Laurent Gouya,et al. The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia , 2004, Schizophrenia Research.
[20] M C O'Donovan,et al. The molecular genetics of schizophrenia: new findings promise new insights , 2004, Molecular Psychiatry.
[21] S. Faraone,et al. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia , 2003, Molecular Psychiatry.
[22] Paul J. Harrison,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .
[23] N. Saitou,et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. , 2003, Human molecular genetics.
[24] I. Gottesman,et al. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia , 2002, BMC psychiatry.
[25] Yusuke Nakamura,et al. A high-throughput SNP typing system for genome-wide association studies , 2001, Journal of Human Genetics.
[26] Alessandro Usiello,et al. Distinct functions of the two isoforms of dopamine D2 receptors , 2000, Nature.
[27] K. Otani,et al. Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[28] S. Kapur,et al. Schizophrenia: more dopamine, more D2 receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] Kevin T. Hansen,et al. Dopamine D2 densities and the schizophrenic brain , 1998, Schizophrenia Research.
[30] J. Thome,et al. Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses , 1998, Journal of Neural Transmission.
[31] T. Arinami,et al. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. , 1997, Human molecular genetics.
[32] J. Nobrega,et al. Dopamine D2‐like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline , 1997, Synapse.
[33] D. Sibley,et al. Functional Analysis of the Human D2 Dopamine Receptor Missense Variants* , 1996, The Journal of Biological Chemistry.
[34] M. Itokawa,et al. Association of dopamine D2 receptor molecular variant with schizophrenia , 1994, The Lancet.
[35] P. Seeman,et al. Dopamine receptor pharmacology. , 1994, Trends in pharmacological sciences.
[36] M. Itokawa,et al. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys). , 1993, Biochemical and biophysical research communications.
[37] D. Sibley,et al. Molecular biology of dopamine receptors. , 1992, Trends in pharmacological sciences.